<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} ACS Infect DisACS Infect DisidaidcbcACS" exact="Infectious" post="Diseases2373-8227American Chemical Society doi: 10.1021/acsinfecdis.0c00052 : Review Broad Spectrum"/>
 <result pre="HealthUnited States *E-mail: jizhou@utmb.edu. Tel: (409) 772-9748. epub: 2020-03-03acsinfecdis.0c00052received: 2020-02-04(C)" exact="American" post="Chemical Society, 2020This article is made available via the"/>
 <result pre="as a global pandemic. Abstract The recent outbreak of coronavirus" exact="disease" post="2019 (COVID-19) highlights an urgent need for therapeutics. Through"/>
 <result pre="FDA-approved anthelminthic drug, was found to be effective against various" exact="viral" post="infections with nanomolar to micromolar potency such as SARS-CoV,"/>
 <result pre="anthelminthic drug, was found to be effective against various viral" exact="infections" post="with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV,"/>
 <result pre="virus human adenovirus This article is made available for a" exact="limited" post="time sponsored by ACS under the ACS Free to"/>
 <result pre="article for non-commercial scholarly purposes. The recent outbreak of coronavirus" exact="disease" post="2019 (COVID-19) first detected in Wuhan, China, was caused"/>
 <result pre="and beta coronaviruses are known to infect humans.2 Human coronavirus" exact="infections" post="are typically mild and rarely associated with severe diseases."/>
 <result pre="associated with severe diseases. However, the epidemics of Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus"/>
 <result pre="with severe diseases. However, the epidemics of Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)"/>
 <result pre="epidemics of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) caused alarming morbidity and mortality.3"/>
 <result pre="of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) caused alarming morbidity and mortality.3 While"/>
 <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) caused alarming morbidity and mortality.3 While coronaviruses"/>
 <result pre="that has been widely used in humans to treat tapeworm" exact="infections" post="for several decades and is currently listed on the"/>
 <result pre="its potential to treat other human conditions15 such as cancer,16âˆ’18" exact="bacterial" post="and viral infections,19âˆ’22 and metabolic diseases.23 These broad biological"/>
 <result pre="to treat other human conditions15 such as cancer,16âˆ’18 bacterial and" exact="viral" post="infections,19âˆ’22 and metabolic diseases.23 These broad biological activities of"/>
 <result pre="pathways were briefly reviewed by Chen et al.15 In this" exact="short" post="review, we focus on summarizing the broad antiviral activities"/>
 <result pre="great potential in being repurposed to treat a variety of" exact="viral" post="infections, such as severe acute respiratory syndrome coronavirus (SARS-CoV),"/>
 <result pre="to treat a variety of viral infections, such as severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus"/>
 <result pre="treat a variety of viral infections, such as severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV),"/>
 <result pre="a variety of viral infections, such as severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Zika"/>
 <result pre="such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese encephalitis virus"/>
 <result pre="as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese encephalitis virus (JEV),"/>
 <result pre="(SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus (ZIKV)," exact="Japanese encephalitis" post="virus (JEV), hepatitis C virus (HCV), Ebola virus (EBOV),"/>
 <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese" exact="encephalitis" post="virus (JEV), hepatitis C virus (HCV), Ebola virus (EBOV),"/>
 <result pre="syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese encephalitis virus (JEV)," exact="hepatitis C" post="virus (HCV), Ebola virus (EBOV), human rhinoviruses (HRVs), Chikungunya"/>
 <result pre="the therapeutic potential to be extended to combat fast-spreading coronavirus" exact="disease" post="2019 (COVID-19), given its inexpensive and low in vivo"/>
 <result pre="profile as an FDA-approved drug in clinical use. Niclosamide and" exact="Viral" post="Infections Niclosamide and Coronavirus Coronaviruses are a group of"/>
 <result pre="as an FDA-approved drug in clinical use. Niclosamide and Viral" exact="Infections" post="Niclosamide and Coronavirus Coronaviruses are a group of enveloped"/>
 <result pre="large genome size ranging from approximately 27 to 34 kb." exact="Infections" post="with human strains HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1 usually"/>
 <result pre="strains HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1 usually cause mild, self-limiting" exact="respiratory" post="infections such as the common cold.2,24 Nevertheless, in the"/>
 <result pre="HCoV-229E, HCoV-OC43, HCoV-NL63, and HCoV-HKU1 usually cause mild, self-limiting respiratory" exact="infections" post="such as the common cold.2,24 Nevertheless, in the past"/>
 <result pre="(SARS-CoV, MERS-CoV, and this yearâ€™s SARS-CoV-2) have caused severe human" exact="disease" post="pandemics associated with high morbidity and mortality. The outbreak"/>
 <result pre="first identified in Saudi Arabia in 2012, has caused a" exact="total" post="of 2519 laboratory-confirmed cases including 866 associated deaths with"/>
 <result pre="of January 2020.25,26 The lack of effective treatment for coronavirus" exact="infections" post="poses a great challenge to clinical management and highlights"/>
 <result pre="niclosamide was able to inhibit SARS-CoV replication and totally abolished" exact="viral" post="antigen synthesis at a concentration of 1.56 Î¼M after"/>
 <result pre="dengue virus four serotypes (DENV 1â€&quot;4), West Nile virus (WNV)," exact="yellow fever" post="virus (YFV), and Japanese encephalitis virus (JEV). Many of"/>
 <result pre="1â€&quot;4), West Nile virus (WNV), yellow fever virus (YFV), and" exact="Japanese encephalitis" post="virus (JEV). Many of these viruses are significant human"/>
 <result pre="West Nile virus (WNV), yellow fever virus (YFV), and Japanese" exact="encephalitis" post="virus (JEV). Many of these viruses are significant human"/>
 <result pre="mosquito-borne flavivirus that is transmitted primarily by Aedes mosquitoes. ZIKV" exact="infection" post="can cause infants to be born with microcephaly and"/>
 <result pre="mosquitoes. ZIKV infection can cause infants to be born with" exact="microcephaly" post="and can trigger neurologic conditions in adults such as"/>
 <result pre="such as Guillainâ€&quot;BarrÃ© syndrome, neuropathy, and myelitis.34âˆ’38 Outbreaks of ZIKV" exact="infection" post="have been recorded several times (2015 in Brazil, the"/>
 <result pre="health emergency. Xu et al. used caspase-3 activity as the" exact="primary" post="screening assay and discovered niclosamide as a potent inhibitor"/>
 <result pre="RNA level.22 The time-of-addition studies indicated that niclosamide inhibits ZIKV" exact="infection" post="at a postentry stage, probably in a viral RNA"/>
 <result pre="inhibits ZIKV infection at a postentry stage, probably in a" exact="viral" post="RNA replication step. Our research team also identified niclosamide"/>
 <result pre="niclosamide inhibits JEV at the stage of replication. Niclosamide and" exact="Hepatitis" post="C Virus Hepatitis C virus (HCV) is an enveloped"/>
 <result pre="at the stage of replication. Niclosamide and Hepatitis C Virus" exact="Hepatitis" post="C virus (HCV) is an enveloped positive-sense single-strand RNA"/>
 <result pre="is transmitted mainly through blood infection. HCV can cause both" exact="acute" post="and chronic hepatitis, and hepatitis C is a major"/>
 <result pre="mainly through blood infection. HCV can cause both acute and" exact="chronic hepatitis," post="and hepatitis C is a major cause of liver"/>
 <result pre="infection. HCV can cause both acute and chronic hepatitis, and" exact="hepatitis C" post="is a major cause of liver cancer. It was"/>
 <result pre="and chronic hepatitis, and hepatitis C is a major cause" exact="of liver" post="cancer. It was estimated that about 71 million people"/>
 <result pre="chronic hepatitis, and hepatitis C is a major cause of" exact="liver cancer." post="It was estimated that about 71 million people have"/>
 <result pre="cancer. It was estimated that about 71 million people have" exact="chronic" post="HCV infections worldwide.43 At present, there is no effective"/>
 <result pre="was estimated that about 71 million people have chronic HCV" exact="infections" post="worldwide.43 At present, there is no effective vaccine against"/>
 <result pre="infections worldwide.43 At present, there is no effective vaccine against" exact="hepatitis C," post="although clinically approved therapeutics are available. Niclosamide was reported"/>
 <result pre="similar to that of its derivatives nitazoxanide and tizoxanide.45âˆ’47 However," exact="chronic" post="HCV infection requires long-term (several months) antiviral treatment, which"/>
 <result pre="that of its derivatives nitazoxanide and tizoxanide.45âˆ’47 However, chronic HCV" exact="infection" post="requires long-term (several months) antiviral treatment, which may make"/>
 <result pre="spreads in the human population through person-to-person transmission. Ebola virus" exact="disease" post="(EVD), known as Ebola hemorrhagic fever, has a high"/>
 <result pre="species (HRV Aâ€&quot;C). HRVs are widespread among humans and the" exact="primary" post="cause of the common cold, posing serious health risks"/>
 <result pre="common cold, posing serious health risks for patients with asthma," exact="chronic" post="pulmonary disease, and severe bronchiolitis in infants and children.49"/>
 <result pre="cold, posing serious health risks for patients with asthma, chronic" exact="pulmonary" post="disease, and severe bronchiolitis in infants and children.49 Niclosamide"/>
 <result pre="risks for patients with asthma, chronic pulmonary disease, and severe" exact="bronchiolitis" post="in infants and children.49 Niclosamide is a weak lipophilic"/>
 <result pre="weak lipophilic acid and was reported to inhibit pH-dependent HRV" exact="infection" post="with low micromolar IC50 values; it suppresses HRV entry"/>
 <result pre="CHIKV causes fever and joint pain, is transmitted by infected" exact="female" post="mosquitoes, and is cataloged as a risk group-3 pathogen."/>
 <result pre="70 different serotypes classified into seven species (HAdV Aâ€&quot;G). HAdV" exact="infections" post="can cause severe and often life-threatening diseases in immunosuppressed"/>
 <result pre="size which is a member of the gamma subfamily of" exact="herpes" post="viruses. EBV is widely spread in humans and infects"/>
 <result pre="of their life, resulting in a lymphoproliferative disorder known as" exact="infectious" post="mononucleosis. EBV infection was also found to be associated"/>
 <result pre="resulting in a lymphoproliferative disorder known as infectious mononucleosis. EBV" exact="infection" post="was also found to be associated with the development"/>
 <result pre="to be associated with the development of several types of" exact="cancer" post="such as Burkittâ€™s lymphoma, Hodgkinâ€™s lymphoma, and nasopharyngeal carcinoma.53"/>
 <result pre="et al. demonstrated that niclosamide inhibits EBV lytic replication in" exact="lymphoma" post="cells and epithelial cells and causes irreversible cell cycle"/>
 <result pre="that niclosamide inhibits EBV lytic replication in lymphoma cells and" exact="epithelial" post="cells and causes irreversible cell cycle arrest in lytic"/>
 <result pre="cells via disrupting mTOR activation, offering the potential to treat" exact="acute" post="EBV-associated infectious diseases.54 Conclusions and Future Directions Niclosamide has"/>
 <result pre="disrupting mTOR activation, offering the potential to treat acute EBV-associated" exact="infectious" post="diseases.54 Conclusions and Future Directions Niclosamide has traditionally been"/>
 <result pre="Future Directions Niclosamide has traditionally been used to treat tapeworm" exact="infections" post="for many years, and it is inexpensive and well"/>
 <result pre="inexpensive and well tolerated in vivo with an extremely high" exact="acute" post="oral LD50 value of &amp;gt;5000 mg/kg in rats (niclosamide"/>
 <result pre="children older than 6 years and adults, respectively, to treat" exact="infections" post="with Taenia solium, T. saginata, and Diphyllobothrium latum.10 Human"/>
 <result pre="infections with Taenia solium, T. saginata, and Diphyllobothrium latum.10 Human" exact="infections" post="with rat tapeworm Hymenolepis diminuta were eliminated by 5â€&quot;7"/>
 <result pre="g of niclosamide each, while the treatment of Hymenolepis nana" exact="infection" post="requires one or several 5â€&quot;7 day courses of niclosamide"/>
 <result pre="be effective against a variety of human conditions such as" exact="cancer" post="and viral infections. Currently, there are four ongoing human"/>
 <result pre="against a variety of human conditions such as cancer and" exact="viral" post="infections. Currently, there are four ongoing human clinical trials"/>
 <result pre="there are four ongoing human clinical trials of niclosamide in" exact="ulcerative colitis," post="prostate carcinoma, and colorectal cancer in the ClinicalTrails.gov clinical"/>
 <result pre="four ongoing human clinical trials of niclosamide in ulcerative colitis," exact="prostate carcinoma," post="and colorectal cancer in the ClinicalTrails.gov clinical trials registry.56"/>
 <result pre="clinical trials of niclosamide in ulcerative colitis, prostate carcinoma, and" exact="colorectal cancer" post="in the ClinicalTrails.gov clinical trials registry.56 Of note, niclosamide"/>
 <result pre="trials of niclosamide in ulcerative colitis, prostate carcinoma, and colorectal" exact="cancer" post="in the ClinicalTrails.gov clinical trials registry.56 Of note, niclosamide"/>
 <result pre="note, niclosamide has several weaknesses such as unneglectable cytotoxicity and" exact="limited" post="aqueous solubility as well as relatively low absorption and"/>
 <result pre="derivative prodrug of niclosamide was also reported to increase its" exact="systemic" post="drug exposure and extend the duration of exposure.59 The"/>
 <result pre="that is responsible for proteolytic processing and is indispensable for" exact="viral" post="replication and the infection process.6 Recently, the high-resolution crystal"/>
 <result pre="proteolytic processing and is indispensable for viral replication and the" exact="infection" post="process.6 Recently, the high-resolution crystal structure of SARS-CoV-2 3CL"/>
 <result pre="University, China. The detailed high-resolution crystal structural analysis of the" exact="viral" post="main proteinase (Mpro) of SARS-CoV-2 may facilitate the in"/>
 <result pre="and R21 AI134568 from the National Institute of Allergy and" exact="Infectious" post="Diseases (NIAID), the National Institutes of Health, John D."/>
 <result pre="R21 AI134568 from the National Institute of Allergy and Infectious" exact="Diseases" post="(NIAID), the National Institutes of Health, John D. Stobo,"/>
 <result pre="ID: 6LU7). Abbreviations Used WHO World Health Organization COVID-19 coronavirus" exact="disease" post="2019 2019-nCoV the 2019 novel coronavirus MERS-CoV Middle East"/>
 <result pre="disease 2019 2019-nCoV the 2019 novel coronavirus MERS-CoV Middle East" exact="respiratory" post="syndrome coronavirus SARS-CoV severe acute respiratory syndrome coronavirus HCV"/>
 <result pre="2019 2019-nCoV the 2019 novel coronavirus MERS-CoV Middle East respiratory" exact="syndrome" post="coronavirus SARS-CoV severe acute respiratory syndrome coronavirus HCV hepatitis"/>
 <result pre="novel coronavirus MERS-CoV Middle East respiratory syndrome coronavirus SARS-CoV severe" exact="acute" post="respiratory syndrome coronavirus HCV hepatitis C virus DENV dengue"/>
 <result pre="coronavirus MERS-CoV Middle East respiratory syndrome coronavirus SARS-CoV severe acute" exact="respiratory" post="syndrome coronavirus HCV hepatitis C virus DENV dengue virus"/>
 <result pre="MERS-CoV Middle East respiratory syndrome coronavirus SARS-CoV severe acute respiratory" exact="syndrome" post="coronavirus HCV hepatitis C virus DENV dengue virus ZIKV"/>
 <result pre="respiratory syndrome coronavirus SARS-CoV severe acute respiratory syndrome coronavirus HCV" exact="hepatitis C" post="virus DENV dengue virus ZIKV Zika virus JEV Japanese"/>
 <result pre="hepatitis C virus DENV dengue virus ZIKV Zika virus JEV" exact="Japanese encephalitis" post="virus WNV West Nile virus YFV yellow fever virus"/>
 <result pre="C virus DENV dengue virus ZIKV Zika virus JEV Japanese" exact="encephalitis" post="virus WNV West Nile virus YFV yellow fever virus"/>
 <result pre="virus JEV Japanese encephalitis virus WNV West Nile virus YFV" exact="yellow fever" post="virus EBOV Ebola virus HRV human rhinovirus CHIKV Chikungunya"/>
 <result pre="D.; CaiJ.-P.; ChengV. C.-C.; ChenH.; HuiC. K.-M.; YuenK.-Y. (2020) A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="C.-C.; ChenH.; HuiC. K.-M.; YuenK.-Y. (2020) A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="family cluster. Lancet395, 514â€&quot;523. 10.1016/S0140-6736(20)30154-9.31986261 collab: World Health Organization. Coronavirus" exact="disease" post="(COVID-2019) situation reports. Situation reports - 45. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ (accessed"/>
 <result pre="collab: World Health Organization. World Health Organization Model List of" exact="Essential" post="Medicines, 21st List, 2019. WeinbachE. C.; GarbusJ. (1969) Mechanism"/>
 <result pre="ArendR. C.; SamantR. S.; BuchsbaumD. J. (2014) Multi-targeted therapy of" exact="cancer" post="by niclosamide: A new application for an old drug."/>
 <result pre="cancer by niclosamide: A new application for an old drug." exact="Cancer" post="Lett.349, 8â€&quot;14. 10.1016/j.canlet.2014.04.003.24732808 LiZ.; BrecherM.; DengY.-Q.; ZhangJ.; SakamuruS.; LiuB.;"/>
 <result pre="(2016) Identification of niclosamide as a novel anticancer agent for" exact="adrenocortical carcinoma." post="Clin. Cancer Res.22, 3458â€&quot;3466. 10.1158/1078-0432.CCR-15-2256.26873959 OsadaT.; ChenM.; YangX. Y.;"/>
 <result pre="niclosamide as a novel anticancer agent for adrenocortical carcinoma. Clin." exact="Cancer" post="Res.22, 3458â€&quot;3466. 10.1158/1078-0432.CCR-15-2256.26873959 OsadaT.; ChenM.; YangX. Y.; SpasojevicI.; VandeusenJ."/>
 <result pre="and elicits antitumor responses in tumors with activating APC mutations." exact="Cancer" post="Res.71, 4172â€&quot;4182. 10.1158/0008-5472.CAN-10-3978.21531761 XuJ.; PachÃ³n-IbÃ¡Ã±ezM. E.; Cebrero-CangueiroT.; ChenH.; SÃ¡nchez-CÃ©spedesJ.;"/>
 <result pre="of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium" exact="tuberculosis" post="(Beijing). Tuberculosis116, S28â€&quot;S33. 10.1016/j.tube.2019.04.008. SunZ.; ZhangY. (1999) Antituberculosis activity"/>
 <result pre="ZhengW.; SongH.; TangH. (2016) Identification of small-molecule inhibitors of Zika" exact="virus infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="SongH.; TangH. (2016) Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="(accessed Feb 26, 2020). collab: World Health Organization. Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). January, 2020. https://www.who.int/emergencies/mers-cov/en/ (acessed Feb 26,"/>
 <result pre="Feb 26, 2020). collab: World Health Organization. Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). January, 2020. https://www.who.int/emergencies/mers-cov/en/ (acessed Feb 26, 2020)."/>
 <result pre="HongC.-F.; LinR.-K.; ChaoY.-S.; HsuJ. T. A. (2004) Inhibition of severe" exact="acute" post="respiratory syndrome coronavirus replication by niclosamide. Antimicrob. Agents Chemother.48,"/>
 <result pre="LinR.-K.; ChaoY.-S.; HsuJ. T. A. (2004) Inhibition of severe acute" exact="respiratory" post="syndrome coronavirus replication by niclosamide. Antimicrob. Agents Chemother.48, 2693â€&quot;2696."/>
 <result pre="ChaoY.-S.; HsuJ. T. A. (2004) Inhibition of severe acute respiratory" exact="syndrome" post="coronavirus replication by niclosamide. Antimicrob. Agents Chemother.48, 2693â€&quot;2696. 10.1128/AAC.48.7.2693-2696.2004.15215127"/>
 <result pre="plant terpenoids and lignoids possess potent antiviral activities against severe" exact="acute" post="respiratory syndrome coronavirus. J. Med. Chem.50, 4087â€&quot;4095. 10.1021/jm070295s.17663539 AnandK.;"/>
 <result pre="terpenoids and lignoids possess potent antiviral activities against severe acute" exact="respiratory" post="syndrome coronavirus. J. Med. Chem.50, 4087â€&quot;4095. 10.1021/jm070295s.17663539 AnandK.; ZiebuhrJ.;"/>
 <result pre="and lignoids possess potent antiviral activities against severe acute respiratory" exact="syndrome" post="coronavirus. J. Med. Chem.50, 4087â€&quot;4095. 10.1021/jm070295s.17663539 AnandK.; ZiebuhrJ.; WadhwaniP.;"/>
 <result pre="AnandK.; BartlamM.; HilgenfeldR.; RaoZ. (2003) The crystal structures of severe" exact="acute" post="respiratory syndrome virus main protease and its complex with"/>
 <result pre="BartlamM.; HilgenfeldR.; RaoZ. (2003) The crystal structures of severe acute" exact="respiratory" post="syndrome virus main protease and its complex with an"/>
 <result pre="HilgenfeldR.; RaoZ. (2003) The crystal structures of severe acute respiratory" exact="syndrome" post="virus main protease and its complex with an inhibitor."/>
 <result pre="WongC.-H. (2005) Discovery of potent anilide inhibitors against the severe" exact="acute" post="respiratory syndrome 3CL protease. J. Med. Chem.48, 4469â€&quot;4473. 10.1021/jm050184y.15974598"/>
 <result pre="(2005) Discovery of potent anilide inhibitors against the severe acute" exact="respiratory" post="syndrome 3CL protease. J. Med. Chem.48, 4469â€&quot;4473. 10.1021/jm050184y.15974598 GassenN."/>
 <result pre="Discovery of potent anilide inhibitors against the severe acute respiratory" exact="syndrome" post="3CL protease. J. Med. Chem.48, 4469â€&quot;4473. 10.1021/jm050184y.15974598 GassenN. C.;"/>
 <result pre="ManuguerraJ.-C.; DespresP.; FournierE.; MalletH.-P.; MussoD.; FontanetA.; NeilJ.; GhawchÃ©F. (2016) Guillain-BarrÃ©" exact="Syndrome" post="outbreak associated with Zika virus infection in French Polynesia:"/>
 <result pre="FontanetA.; NeilJ.; GhawchÃ©F. (2016) Guillain-BarrÃ© Syndrome outbreak associated with Zika" exact="virus infection" post="in French Polynesia: a case-control study. Lancet387, 1531â€&quot;1539. 10.1016/S0140-6736(16)00562-6.26948433"/>
 <result pre="NeilJ.; GhawchÃ©F. (2016) Guillain-BarrÃ© Syndrome outbreak associated with Zika virus" exact="infection" post="in French Polynesia: a case-control study. Lancet387, 1531â€&quot;1539. 10.1016/S0140-6736(16)00562-6.26948433"/>
 <result pre="A. S. M.; MarchioriE. (2016) Magnetic resonance imaging findings in" exact="Guillain-Barre syndrome" post="caused by Zika virus infection. Neuroradiology58, 837â€&quot;838. 10.1007/s00234-016-1687-9.27067205 ChambersT."/>
 <result pre="S. M.; MarchioriE. (2016) Magnetic resonance imaging findings in Guillain-Barre" exact="syndrome" post="caused by Zika virus infection. Neuroradiology58, 837â€&quot;838. 10.1007/s00234-016-1687-9.27067205 ChambersT."/>
 <result pre="Magnetic resonance imaging findings in Guillain-Barre syndrome caused by Zika" exact="virus infection." post="Neuroradiology58, 837â€&quot;838. 10.1007/s00234-016-1687-9.27067205 ChambersT. J.; GrakouiA.; RiceC. M. (1991)"/>
 <result pre="10.1007/s00234-016-1687-9.27067205 ChambersT. J.; GrakouiA.; RiceC. M. (1991) Processing of the" exact="yellow fever" post="virus nonstructural polyprotein: a catalytically active NS3 proteinase domain"/>
 <result pre="ChenH.; SongY. (2013) Identification of three antiviral inhibitors against japanese" exact="encephalitis" post="virus from library of pharmacologically active compounds 1280. PLoS"/>
 <result pre="active compounds 1280. PLoS One8, e7842510.1371/journal.pone.0078425.24348901 collab: World Health Organization." exact="Hepatitis" post="C. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c (accessed Jan 29, 2020). StachulskiA. V.; PidathalaC.;"/>
 <result pre="RossignolJ.-F. (2011) Thiazolides as novel antiviral agents. 2. Inhibition of" exact="hepatitis C" post="virus replication. J. Med. Chem.54, 8670â€&quot;8680. 10.1021/jm201264t.22059983 KorbaB. E.;"/>
 <result pre="KorbaB. E.; ElazarM.; LuiP.; RossignolJ.-F.; GlennJ. S. (2008) Potential for" exact="hepatitis C" post="virus resistance to nitazoxanide or tizoxanide. Antimicrob. Agents Chemother.52,"/>
 <result pre="KuoS.-C.; HoY.-J. (2016) Antiviral activities of niclosamide and nitazoxanide against" exact="chikungunya" post="virus entry and transmission. Antiviral Res.135, 81â€&quot;90. 10.1016/j.antiviral.2016.10.003.27742486 Marrugal-LorenzoJ."/>
 <result pre="Niclosamide as a treatment for Hymenolepis diminuta and Dipylidium caninum" exact="infection" post="in man. Am. J. Trop. Med. Hyg.28, 300â€&quot;302. 10.4269/ajtmh.1979.28.300.572147"/>
 <result pre="LaiH.-C. (2016) Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in" exact="ovarian cancer." post="Oncotarget.7, 8993â€&quot;9006. 10.18632/oncotarget.7113.26848771 WrappD.; WangN.; CorbettK. S.; GoldsmithJ. A.;"/>
 <result pre="ChenQ.-J.; DengF.; LiuL.-L.; YanB.; ZhanF.-X.; WangY.-Y.; XiaoG.-F.; ShiZ.-L. (2020) A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
</results>
